Leukemia - Acute Myeloid - AML - Childhood


Blood Cancer OncTalk was a live presentation that brought together top oncologists to discuss emerging concepts and treatment options in blood cancer. The program was chaired by Dr. Aaron Goodman, with the participation of Dr. Mazie Tsang, Hematologist / Oncologist; Dr. Autumn Jeong, Hematologist / Oncologist; Dr. Shaji Kumar, Hematologist / Oncologist; and Dr. Sridevi Rajeeve, Hematologist / Oncologist.
In this video, Drs. Tsang, Kumar, Rajeeve, Jeong, and Goodman examine risk factors for developing blood cancer.
A huge thank you to our sponsor #Pharmacyclics
For more, please visit http://cancerGRACE.org/.
To join the conversation, visit https://cancergrace.org/forum.
Music by Bensound.com/royalty-free-music
License code: RB6S1WVPWK7TWMIA


The ICR's Professor Sir Mel Greaves talks about how a major new analysis has revealed for the first time the likely cause of most cases of childhood leukaemia and that the disease may be preventable.
Find out more in our news story: https://buff.ly/2KHuXos
Donate to our childhood leukaemia appeal: https://www.icr.ac.uk/ALL
Question and answer videos:
What causes mutations to occur in the womb? - https://youtu.be/jgs2Bjet268
What are the next steps for leukaemia research? - https://youtu.be/mRZmOP8HYAc
Why is leukaemia prevention so important? - https://youtu.be/PYb-rmI7HIw
What can parents do to reduce their child's risk of leukaemia? - https://youtu.be/dUMu2exV2SI


Diagnosed with acute lymphoblastic leukemia (ALL) just before his 12th birthday, Luke Theodosiades’ parents turned to investigational treatments to control their eldest child’s cancer. Learn how cancer research is benefiting pediatric cancer patients like Luke at www.AACR.org/CancerProgressReport.


It was a typical morning when Elaina’s parents received a call from the doctor, confirming the unexpected result of her bloodwork: “We think it’s leukemia.” Elaina’s family packed their bags and headed to Children’s Mercy Kansas City where Elaina immediately started receiving therapy and care from the Hematology/Oncology team. Watch Elaina’s story to hear her journey to remission and the challenges she faces due to disparities in research for the Hispanic population.
About the Spanish-Speaking Cancer Clinic
Clear communication between families and care providers leads to much better health results for children. That’s why Children’s Mercy offers the HOPE Clinic (Clinica de Hematologia/Oncologia: Puente de Esperanza) for kids with cancer from Spanish-speaking families.
About the Cancer Center
The Children's Mercy oncology program is a national leader in cancer treatment. Our program provides children and teens with comprehensive clinical services and innovative treatment—including Phase I Experimental Therapeutics, stem cell transplantation, and immunotherapies such as CAR T-cell—supported by the latest research.
Learn more at www.childrensmercy.org/cancer